MEI Pharma Stock (NASDAQ: MEIP) stock price, news, charts, stock research, profile.
Open | $3.260 |
Close | $3.100 |
Volume / Avg. | 16.736K / 21.347K |
Day Range | 3.100 - 3.260 |
52 Wk Range | 3.200 - 7.970 |
Market Cap | $26.650M |
P/E Ratio | 1.094 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 0.14% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MEI Pharma (NASDAQ: MEIP) through any online brokerage.
Other companies in MEI Pharma’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), T2 Biosystems (NASDAQ:TTOO) and Lumos Pharma (NASDAQ:LUMO).
The latest price target for MEI Pharma (NASDAQ: MEIP) was reported by Stifel on Friday, April 12, 2024. The analyst firm set a price target for 7.00 expecting MEIP to rise to within 12 months (a possible 75.01% upside). 5 analyst firms have reported ratings in the last year.
The stock price for MEI Pharma (NASDAQ: MEIP) is $3.9998 last updated April 11, 2024 at 8:23 AM EDT.
There are no upcoming dividends for MEI Pharma.
MEI Pharma’s Q3 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for MEI Pharma.
MEI Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.